
Axela Technologies
Helps community associations bring their delinquency rate to zero through an automated software platform.
Date | Investors | Amount | Round |
---|---|---|---|
investor investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
N/A | Series A | ||
Total Funding | 000k |
USD | 2021 | 2022 | 2023 |
---|---|---|---|
Revenues | 0000 | 0000 | 0000 |
% growth | - | 115 % | 28 % |
EBITDA | 0000 | 0000 | 0000 |
Profit | 0000 | 0000 | 0000 |
EV | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Related Content
Axela Biosensors specializes in developing cutting-edge biosensor technology for real-time health monitoring. The company serves healthcare providers, research institutions, and pharmaceutical companies, operating primarily in the medical technology market. Axela's business model revolves around the sale of its proprietary biosensor devices and accompanying data analytics services. Revenue is generated through direct sales, subscription-based data services, and partnerships with healthcare organizations. The company's core product is a biosensor that provides continuous, accurate health data, enabling better patient care and more informed medical decisions. Axela's technology stands out for its precision, ease of use, and integration capabilities with existing healthcare systems.
Keywords: biosensors, health monitoring, medical technology, data analytics, healthcare providers, research institutions, pharmaceutical companies, real-time data, patient care, proprietary technology.